Drug-Peptide Conjugates Change Structure and Membrane Interactions for TB Drug Delivery
Conjugating the TB drug isoniazid to cell-penetrating peptides altered their structure and membrane interactions, with different CPPs showing similar cell entry but markedly different subcellular localization and anti-TB activity.
Quick Facts
What This Study Found
INH-CPP conjugates showed conjugation-induced structural and membrane interaction changes that correlated with each other; Penetratin and Transportan conjugates had similar cell uptake but different subcellular localization and anti-Mtb activity.
Key Numbers
Multiple CPPs tested; Penetratin and Transportan conjugates had similar uptake but different localization and anti-Mtb activity
How They Did This
In-vitro study using Langmuir balance membrane interaction assays, circular dichroism spectroscopy, AFM imaging, and cellular uptake/anti-Mtb activity assays with INH-CPP conjugates.
Why This Research Matters
TB kills over a million people annually. CPP-delivered drugs that reach the right intracellular compartments could improve treatment of this hard-to-reach pathogen.
The Bigger Picture
This study reveals that for intracellular drug delivery, getting inside the cell is not enough — the CPP must also deliver cargo to the right subcellular compartment where the pathogen resides.
What This Study Doesn't Tell Us
In-vitro study with one cancer cell line; limited Mtb strains tested; conjugation may affect INH drug activity independently of delivery; in-vivo pharmacokinetics not assessed.
Questions This Raises
- ?Which CPP delivers INH specifically to the phagosome where Mtb resides?
- ?Could CPP selection be optimized based on subcellular targeting to improve TB treatment?
- ?How do INH-CPP conjugates perform against drug-resistant TB strains?
Trust & Context
- Key Stat:
- Same entry, different destination Penetratin and Transportan INH conjugates entered cells equally but had markedly different subcellular localization and anti-Mtb activity
- Evidence Grade:
- Comprehensive biophysical characterization with complementary techniques, but preliminary biological evaluation limited to one cell line and in-vitro conditions.
- Study Age:
- Published in 2020; CPP-based TB drug delivery remains an active research area addressing intracellular pathogen treatment.
- Original Title:
- Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides.
- Published In:
- International journal of molecular sciences, 21(6) (2020)
- Authors:
- Pári, Edit, Horváti, Kata, Bősze, Szilvia, Biri-Kovács, Beáta, Szeder, Bálint, Zsila, Ferenc, Kiss, Éva
- Database ID:
- RPEP-05078
Evidence Hierarchy
Frequently Asked Questions
Can peptides help deliver TB drugs inside cells?
Cell-penetrating peptides can carry TB drugs into cells where the bacteria hide, but this study shows the peptide must deliver the drug to the right compartment inside the cell to be effective.
Why is TB hard to treat?
TB bacteria hide inside human immune cells in specific compartments. Drugs must not only enter cells but reach these compartments to kill the bacteria — a challenge that CPP delivery aims to solve.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05078APA
Pári, Edit; Horváti, Kata; Bősze, Szilvia; Biri-Kovács, Beáta; Szeder, Bálint; Zsila, Ferenc; Kiss, Éva. (2020). Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides.. International journal of molecular sciences, 21(6). https://doi.org/10.3390/ijms21062197
MLA
Pári, Edit, et al. "Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides.." International journal of molecular sciences, 2020. https://doi.org/10.3390/ijms21062197
RethinkPeptides
RethinkPeptides Research Database. "Drug Conjugation Induced Modulation of Structural and Membra..." RPEP-05078. Retrieved from https://rethinkpeptides.com/research/pari-2020-drug-conjugation-induced-modulation
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.